Drug data last refreshed 7h ago · AI intelligence enriched 1w ago
Nitrous Oxide, USP is an inhalation gas approved as a pharmaceutical product by Advanced Solutions Life Sciences. It is a general anesthetic and analgesic agent used in medical and dental settings to provide pain relief and sedation during procedures.
Product is in peak lifecycle stage with established market presence; commercial teams likely focused on market maintenance and competitive positioning.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Nitrous Oxide Prior to Intranasal Midazolam for Moderate Dental Sedation in Pediatric Patients
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
A Comparison of Intranasal Midazolam and Nitrous Oxide (N2O) Minimal Sedation for Minor Procedures in a Pediatric Emergency Department
Nitrous Oxide Versus Intravenous Sedation for Anesthesia
Nitrous Oxide for Pain Management During In-office Transcervical Sterilization
Worked on NITROUS OXIDE, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Advanced Solutions Life Sciences is hiring 1 role related to this product
Only one linked job posting identified for this product, primarily in IT/technical testing functions rather than traditional pharmaceutical commercial roles. Career opportunities appear limited and specialized, focused on operational and systems support rather than marketing or sales.
1 open roles linked to this drug